SB

Samuel Bjork

Partner at Digitalis Ventures

Brooklyn, New York

VC
Investor

Invests in

Stages:

Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Education

Investments

T-Therapeutics

Series A

Total Funding: $60M

EpiBiologics

Series A

Total Funding: $96M

Bonum Therapeutics

Series A

Total Funding: $93M

Good Therapeutics

Series A

Total Funding: $30M

MollyBox

Series B

Total Funding: $13M

Work Experience

Digitalis Ventures

2018

  • Partner

    2018

Columbia Technology Ventures

2016 - 2017

  • Strategic Advisor

    2016 - 2017

The Boston Consulting Group

2013 - 2016

  • Project Leader

    2013 - 2016

University of Cambridge

2010 - 2012

  • Graduate Research

    2010 - 2012

Harvard University

2007 - 2011

  • Laboratory Research

    2007 - 2011

Fourth Floor Productions (Office of Errol Morris)

2007 - 2011

  • Researcher + Production Assistant

    2007 - 2011